CGNM UK LTD.

Figures converted to GBP from USD at 0.748 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -8.1%

  USD 272,066,000 → USD 250,062,000

• Cash

  -94.7%

  USD 47,395,000 → USD 2,523,000

• Net assets

  +26.2%

  USD 162,662,779 → USD 205,250,804

• Employees

  -77.8%

  9 → 2

• Operating profit

  +8.1%

  USD -714,000 → USD -656,000

• Profit before tax

  +51.5%

  USD 42,429,000 → USD 64,291,000

• Wages

  -86.6%

  USD 642,000 → USD 86,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Shinewing Wilson Accountancy Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The financial statements are prepared on a going concern basis which assumes that the company will continue in operational existence for the foreseeable future.”

Significant events

• “In 2025 the company has made a profit, this was a result of trading income and receiving a dividend from investment in the associate Ortalyk LLP of $73,211,000 (2024: $56,780,000).”
• “In the year turnover decreased by 8% mainly due to the decrease in uranium price. Profit before tax increased due to dividends of $73 million (2024: S57 million) received from the associate which led to the increase in the shareholder's funds.”
• “The loan, which was originally due in November 2025, was repaid on time. Subsequently, the company entered into a new loan agreement of US$125 million, with a maturity date of November 2028.”
• “During the year ended 31 December 2025, the Company fully repaid the outstanding principal and accrued interest in November 2025. In the same month, the Company entered into a new facility agreement of US$125 million, which is repayable in November 2028 with on demand clause.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.